Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Rapid Micro Biosystems Inc (NASDAQ: RPID) was $3.72 for the day, down -4.62% from the previous closing price of $3.90. In other words, the price has decreased by -$4.62 from its previous closing price. On the day, 0.74 million shares were traded.
Ratios:
Our analysis of RPID’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.19 and its Current Ratio is at 5.52. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, KeyBanc Capital Markets on February 12, 2025, initiated with a Overweight rating and assigned the stock a target price of $8.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 03 ’24 when PEI MELINDA LITHERLAND bought 10,880 shares for $1.00 per share. The transaction valued at 10,880 led to the insider holds 45,180 shares of the business.
PEI MELINDA LITHERLAND bought 9,120 shares of RPID for $9,484 on Dec 05 ’24. The Director now owns 54,300 shares after completing the transaction at $1.04 per share. On Nov 27 ’24, another insider, PEI MELINDA LITHERLAND, who serves as the Director of the company, bought 19,892 shares for $1.05 each. As a result, the insider paid 20,887 and bolstered with 34,300 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 6.12 while its Price-to-Book (P/B) ratio in mrq is 1.90.
Stock Price History:
Over the past 52 weeks, RPID has reached a high of $4.00, while it has fallen to a 52-week low of $0.58. The 50-Day Moving Average of the stock is 130.43%, while the 200-Day Moving Average is calculated to be 255.62%.
Shares Statistics:
A total of 37.72M shares are outstanding, with a floating share count of 20.43M. Insiders hold about 52.52% of the company’s shares, while institutions hold 15.94% stake in the company.
Earnings Estimates
A comprehensive evaluation of Rapid Micro Biosystems Inc (RPID) is underway, with the input of 2.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.21 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$1.06 and -$1.09 for the fiscal current year, implying an average EPS of -$1.08. EPS for the following year is -$0.89, with 2.0 analysts recommending between -$0.88 and -$0.91.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 1 analysts. It ranges from a high estimate of $8.2M to a low estimate of $8.2M. As of the current estimate, Rapid Micro Biosystems Inc’s year-ago sales were $6.34MFor the next quarter, 1 analysts are estimating revenue of $6.6M. There is a high estimate of $6.7M for the next quarter, whereas the lowest estimate is $6.5M.
A total of 1 analysts have provided revenue estimates for RPID’s current fiscal year. The highest revenue estimate was $28.1M, while the lowest revenue estimate was $28.1M, resulting in an average revenue estimate of $28.1M. In the same quarter a year ago, actual revenue was $22.52MBased on 3 analysts’ estimates, the company’s revenue will be $32.9M in the next fiscal year. The high estimate is $34.2M and the low estimate is $31.4M.
